These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 2839719)
41. Pathogenicity in mice of herpes simplex virus type 2 mutants unable to express glycoprotein C. Johnson DC; McDermott MR; Chrisp C; Glorioso JC J Virol; 1986 Apr; 58(1):36-42. PubMed ID: 3005656 [TBL] [Abstract][Full Text] [Related]
42. Herpes simplex virus DNA sequences in the CNS of latently infected mice. Cabrera CV; Wohlenberg C; Openshaw H; Rey-Mendez M; Puga A; Notkins AL Nature; 1980 Nov; 288(5788):288-90. PubMed ID: 6253827 [TBL] [Abstract][Full Text] [Related]
43. Pathogenicity of glycoprotein C negative mutants of herpes simplex virus type 1 for the mouse central nervous system. Sunstrum JC; Chrisp CE; Levine M; Glorioso JC Virus Res; 1988 Aug; 11(1):17-32. PubMed ID: 2845681 [TBL] [Abstract][Full Text] [Related]
44. Replacement of glycoprotein B gene sequences in herpes simplex virus type 1 strain ANG by corresponding sequences of the strain KOS causes changes of plaque morphology and neuropathogenicity. Weise K; Kaerner HC; Glorioso J; Schröder CH J Gen Virol; 1987 Jul; 68 ( Pt 7)():1909-19. PubMed ID: 3037014 [TBL] [Abstract][Full Text] [Related]
45. Does restriction enzyme analysis reveal changes in herpes simplex virus DNA after latency in mouse ganglia? Wolff MH; Krämer S; Schneweis KE Microbiologica; 1986 Apr; 9(2):139-45. PubMed ID: 3012286 [TBL] [Abstract][Full Text] [Related]
46. Herpes simplex virus infection in populations of mouse dorsal root ganglion neurons: effects of inoculation route and virus strain. Henken DB; Martin JR J Neurol Sci; 1991 Sep; 105(1):29-36. PubMed ID: 1665505 [TBL] [Abstract][Full Text] [Related]
47. Nucleotide sequences responsible for the inability of a herpes simplex virus type 2 strain to grow in human lymphocytes are identical to those responsible for its inability to grow in mouse tissues following ocular infection. Lausch RN; Yeung KC; Miller JZ; Oakes JE Virology; 1990 Jun; 176(2):319-28. PubMed ID: 2161143 [TBL] [Abstract][Full Text] [Related]
48. Viral genes modify herpes simplex virus latency both in mouse footpad and sensory ganglia. Al-Saadi SA; Clements GB; Subak-Sharpe JH J Gen Virol; 1983 May; 64(Pt 5):1175-9. PubMed ID: 6302212 [TBL] [Abstract][Full Text] [Related]
49. Acute and recurrent infection with herpes simplex virus in the mouse: a model for studying latency and recurrent disease. Hill TJ; Field HJ; Blyth WA J Gen Virol; 1975 Sep; 28(3):341-53. PubMed ID: 170376 [TBL] [Abstract][Full Text] [Related]
50. Intertypic superinfection of herpes simplex virus in vivo leads to reisolation of latent viruses with newly acquired lymphotropic properties. Darai G; Scholz J; Kurz W; Koch HG Dev Biol Stand; 1982; 52():67-80. PubMed ID: 6299861 [TBL] [Abstract][Full Text] [Related]
51. The pathogenicity of ribonucleotide reductase-null mutants of herpes simplex virus type 1 in mice. Yamada Y; Kimura H; Morishima T; Daikoku T; Maeno K; Nishiyama Y J Infect Dis; 1991 Dec; 164(6):1091-7. PubMed ID: 1659596 [TBL] [Abstract][Full Text] [Related]
52. Herpes simplex virus type 2 latency in the footpad of mice: effect of acycloguanosine on the recovery of virus. Al-Saadi SA; Gross P; Wildy P J Gen Virol; 1988 Feb; 69 ( Pt 2)():433-8. PubMed ID: 2828517 [TBL] [Abstract][Full Text] [Related]
53. Neuronal control of herpes simplex virus latency. Tenser RB; Edris WA; Hay KA Virology; 1993 Aug; 195(2):337-47. PubMed ID: 8393231 [TBL] [Abstract][Full Text] [Related]
54. Intrastrain variants of herpes simplex virus type 1 isolated from a neonate with fatal disseminated infection differ in the ICP34.5 gene, glycoprotein processing, and neuroinvasiveness. Bower JR; Mao H; Durishin C; Rozenbom E; Detwiler M; Rempinski D; Karban TL; Rosenthal KS J Virol; 1999 May; 73(5):3843-53. PubMed ID: 10196279 [TBL] [Abstract][Full Text] [Related]
55. Apparent stability of herpes simplex virus genomes isolated from primary and recurrent infections and dorsal root ganglia in the mouse. Blondeau JM; Embil JA; McFarlane ES J Med Microbiol; 1988 Dec; 27(4):291-6. PubMed ID: 2848947 [TBL] [Abstract][Full Text] [Related]
56. Dissemination of herpes simplex virus in ganglia after footpad inoculation in neurectomized and non-neurectomized mice. Klein RJ; DeStefano E Arch Virol; 1983; 77(2-4):231-8. PubMed ID: 6314936 [TBL] [Abstract][Full Text] [Related]
57. Divergent molecular pathways of productive and latent infection with a virulent strain of herpes simplex virus type 1. Speck PG; Simmons A J Virol; 1991 Aug; 65(8):4001-5. PubMed ID: 1649313 [TBL] [Abstract][Full Text] [Related]
58. Transduction of virulence in herpes simplex virus type 1 from a pathogenic to an apathogenic strain by a cloned viral DNA fragment. Rösen A; Gelderblom H; Darai G Med Microbiol Immunol; 1985; 173(5):257-78. PubMed ID: 2982083 [TBL] [Abstract][Full Text] [Related]
59. Comparative neurovirulence and latency of HSV1 and HSV2 following footpad inoculation in mice. McKendall RR J Med Virol; 1980; 5(1):25-32. PubMed ID: 6247441 [TBL] [Abstract][Full Text] [Related]
60. Mechanism of differences in pathogenicity between two variants of a laboratory strain of herpes simplex virus type 1. Yamada M; Arao Y; Uno F; Nii S Microbiol Immunol; 1986; 30(12):1259-70. PubMed ID: 2437431 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]